Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radioactive hope: first human test for tough prostate cancer

NCT ID NCT06492122

Recruiting now Disease control Sponsor: Full-Life Technologies GmbH Source: ClinicalTrials.gov ↗

Summary

This is the first-ever study in people to test a new radioactive drug called [225Ac]Ac-FL-020 for men with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also check if it helps control the cancer in about 50 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara Üniversitesi Tıp Fakültesi Cebeci Hastanesi Nükleer Tıp Anabilim Dalı

    RECRUITING

    Ankara, 06590, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, 100142, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Chao Family Comprehensive Cancer Center

    RECRUITING

    Irvine, California, 92612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

    Contact

    Contact

  • Genesiscare Murdoch

    RECRUITING

    Murdoch, Australia

    Contact

    Contact

  • MacQuarie University Clinical Trial Unit

    RECRUITING

    Sydney, NSW 2109, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Princess Alexandra Hospital

    RECRUITING

    Brisbane, Australia

    Contact

    Contact

  • University of Stanford

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact

    Contact

  • University of Virginia Cancer Center

    RECRUITING

    Charlottesville, Virginia, 22903, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER